Boston Scientific supports STENT thrombosis study

Interventional device developer Boston Scientific said it will provide lead support for an extension of the Strategic Transcatheter Evaluation of New Therapies (STENT) drug-eluting stent registry to study the effects of late stent thrombosis in drug-eluting stents.

The multicenter registry will begin enrolling the approximately 10,000 patients for the study in early 2007, according to Boston Scientific of Natick, MA.

By AuntMinnie.com staff writers
October 24, 2006

Related Reading

Boston nets CE mark, October 16, 2006

Boston Scientific taps Japp, October 11, 2006

Boston Scientific introduces FlexView, September 20, 2006

Boston Scientific reaches halfway point in drug-eluting stent trial, August 31, 2006

Boston Scientific posts powerful Q2 sales, July 27, 2006

Copyright © 2006 AuntMinnie.com

Page 1 of 181
Next Page